Patents by Inventor Albert Radlmaier

Albert Radlmaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wafer Comprising Steroid Hormones
    Publication number: 20170348321
    Abstract: The invention relates to a pharmaceutical composition in the form of a system in film form for transmucosal administration of steroid hormones. An administration system for steroid hormones which dissolves in the mouth and which releases with a high bioavailability is disclosed. The administration system in film form dissolves in the mouth preferably in a period of less than 30 min, and the steroid hormone entering the bloodstream transmucosally from the administration system leads to a rapid rise in the concentration in the blood. It is thus possible to achieve a maximum concentration of this steroid hormone in the blood in a period of less than 60 min after administration.
    Type: Application
    Filed: August 23, 2017
    Publication date: December 7, 2017
    Applicant: LTS Lohmann Therapie-Systeme AG
    Inventors: Markus Krumme, Albert Radlmaier, Sescha General, Michael Dittgen, Keith Jensen
  • Wafer comprising steroid hormones
    Patent number: 9763960
    Abstract: The invention relates to a pharmaceutical composition in the form of a system in film form for transmucosal administration of steroid hormones. An administration system for steroid hormones which dissolves in the mouth and which releases with a high bioavailability is disclosed. The administration system in film form dissolves in the mouth preferably in a period of less than 30 min, and the steroid hormone entering the bloodstream transmucosally from the administration system leads to a rapid rise in the concentration in the blood. It is thus possible to achieve a maximum concentration of this steroid hormone in the blood in a period of less than 60 min after administration.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: September 19, 2017
    Assignee: LTS Lohmann Theraple-Systeme AG
    Inventors: Markus Krumme, Albert Radlmaier, Sascha General, Michael Dittgen, Keith Jensen
  • Wafer comprising steroid hormones
    Publication number: 20060222708
    Abstract: The invention relates to a pharmaceutical composition in the form of a system in film form for transmucosal administration of steroid hormones. An administration system for steroid hormones which dissolves in the mouth and which releases with a high bioavailability is disclosed. The administration system in film form dissolves in the mouth preferably in a period of less than 30 min, and the steroid hormone entering the bloodstream transmucosally from the administration system leads to a rapid rise in the concentration in the blood. It is thus possible to achieve a maximum concentration of this steroid hormone in the blood in a period of less than 60 min after administration.
    Type: Application
    Filed: March 28, 2006
    Publication date: October 5, 2006
    Inventors: Markus Krumme, Albert Radlmaier, Sascha General, Michael Dittgen, Keith Jensen
  • Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
    Patent number: 6696432
    Abstract: The present invention concerns the combination of dehydroepiandrosterone (DHEA) and at least one aromatase inhibitor and the use of such a combination to produce a medicament for treating relative and/or absolute androgen deficiency in men. Selective aromatase inhibitors such as atamestan, formestan, pentrozol, aramidex, fadrozol, CGS 20267 and/or vorozol, are preferred for producing the medicament according to the invention.
    Type: Grant
    Filed: November 3, 1998
    Date of Patent: February 24, 2004
    Assignee: Schering Aktiengesellschaft
    Inventors: Jörg Elliesen, Albert Radlmaier, Ursula Habenicht, Friedmund Neumann
  • Methods of treating androgen deficiency in men using selective aromatase inhibitors
    Patent number: 5861389
    Abstract: Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of aromatase inhibitors to men experiencing male menopause can remedy the relative androgen deficiency in men while at the same time approximating the physiological hormonal ratio of androgens to estrogens.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: January 19, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Albert Radlmaier, Ursula-Friederike Habenicht, Friedmund Neumann